Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
5
Neutral
3
Bullish
6
Bearish
37
Neutral
3
Bullish
6
Bearish
32
Neutral
0
Bullish
0
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY22
Indo National Ltd (NIPPOBATRY) is currently trading at 300.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Indo National Limited (Nippo) is a consumer goods manufacturer and marketer primarily of dry batteries, torches, LED lighting, mosquito bats, electrical accessories and razors, supported by a national distribution network with 22 depots and over 3,500 distributors; the company also holds subsidiaries active in investments, green energy and recently acquired medical solutions exposure. Financially the company reported a weak quarter: standalone revenue of Rs.106.11 crore for Q3FY26 but a loss before tax of Rs.7.23 crore and standalone net loss of Rs.6.62 crore, while consolidated results reflect segmental complexity and a negative EPS in the quarter, signalling near-term margin stress and volatility for Indo National Limited. During the nine months ended December 31, 2025 Indo National Limited made strategic investments and structural changes — acquisition of Medcuore, CCPS investment in Axial Aero, and an NCLT amalgamation petition for Helios — that materially reshape the group’s asset mix and strategic focus beyond pure battery manufacturing. Regulatory and contingent issues are material: the company deposited Rs.4.22 crore under stay of a Rs.42.26 crore CCI penalty and recognized a past-period employee benefit liability (~Rs.86–87 lakhs) due to new labour codes; these items increase contingent risk and may influence reported profitability and cash deployment for Indo National Limited.
Over the past 52 weeks, Indo National Ltd has traded between a low of ₹255.00 and a high of ₹472.25. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Indo National Ltd has a market capitalization of approximately 229.61. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Indo National Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -8.92 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 229.61 Cr, Indo National Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Indo National Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Indo National Ltd is -8.92. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The National Company Law Tribunal (NCLT), Chennai Bench, approved the Scheme of Amalgamation for the merger of Helios Strategic Systems Limited into Indo-National Limited on March 10, 2026.

Household Products
Household Products
230 Cr
Moderate Risk
-8.9
27.1
—
0.8
472.25
255.00
Sales CAGR
Profit CAGR
ROE
ROCE